000 | 01901 a2200529 4500 | ||
---|---|---|---|
005 | 20250516154122.0 | ||
264 | 0 | _c20140114 | |
008 | 201401s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0060562 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSinger, Elizabeth | |
245 | 0 | 0 |
_aStromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia. _h[electronic resource] |
260 |
_bPloS one _c2013 |
||
300 |
_ae60562 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xmetabolism |
650 | 0 | 4 | _aCryopreservation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aMacrophages _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNanotechnology _xmethods |
650 | 0 | 4 |
_aNeutrophils _xmetabolism |
650 | 0 | 4 |
_aPeroxiredoxins _xgenetics |
650 | 0 | 4 |
_aProstate _xmetabolism |
650 | 0 | 4 | _aProstatectomy |
650 | 0 | 4 |
_aProstatic Hyperplasia _xdiagnosis |
650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnosis |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aStaining and Labeling |
650 | 0 | 4 |
_aStromal Cells _xmetabolism |
650 | 0 | 4 |
_aThioredoxin Reductase 1 _xgenetics |
650 | 0 | 4 |
_aThioredoxin Reductase 2 _xgenetics |
700 | 1 | _aLinehan, Jennifer | |
700 | 1 | _aBabilonia, Gail | |
700 | 1 | _aImam, S Ashraf | |
700 | 1 | _aSmith, David | |
700 | 1 | _aLoera, Sofia | |
700 | 1 | _aWilson, Timothy | |
700 | 1 | _aSmith, Steven | |
773 | 0 |
_tPloS one _gvol. 8 _gno. 6 _gp. e60562 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0060562 _zAvailable from publisher's website |
999 |
_c22831731 _d22831731 |